Gold Michael H, Andriessen Anneke, Biron Julie, Andriessen Hinke
J Clin Aesthet Dermatol. 2009 Mar;2(3):44-50.
This study was an evaluation of the performance of self-applied, blue light, light-emitting diode therapy in the treatment of mild-to-moderate inflammatory acne on the face, concerning: 1) time to improvement and/or resolution of the number of blemishes and lesions on the face; 2) quality of skin condition; 3) occurrence and count of the number of new blemishes and lesions; and 4) ease of product use; patient comfort, wellbeing, and satisfaction during the treatment period; and safety of treatment. Subjects (N=21) were included according to the inclusion/exclusion criteria and after they had given informed consent. The blue light treatment was conducted over an eight-week period. For study data management and analysis, SPSS 16.0 statistical software was used. Data management and analysis was performed independently using, where appropriate, ANOVA, student t-test, and Mann-Whitney test for N=20. Tests were carried out at the five-percent significance level. The confidence interval was 95 percent. Twenty-one subjects concluded the study (18/21 were female and 3/21 were male). Upon the first outbreak of acne, subjects had a mean age of 15 years (range 8-28 years), and 19 subjects had mild-to-moderate acne for a mean duration of 13.1 years. During the study period with self-applied blue light treatment, the total number of comedones on the face had significantly reduced for the assessment at Day 7 (p<0.019) and at Day 28 (p<0.001). The total number of open comedones (blackheads) on the face during the treatment period was reduced significantly (p<0.02) for assessment at treatment Day 7 (p<0.005) and for the assessment at Day 28. The total number of closed comedones (whiteheads) on the face during the treatment period, was reduced significantly (p<0.007) for the assessment at Day 28. The total number of papules during treatment had reduced significantly for assessment at Day 7 (p<0.048) and Day 28 (p<0.005). The total number of pustules during treatment had reduced, but this difference was not statistically significant. This was similar for nodules present. Subjects expressed confidence in using the self-applied blue light without the supervision of a doctor. Regarding previous treatments, subjects expressed dissatisfaction and considered self-applied blue light treatment to be better for their condition. Self-applied blue light treatment was reported to be easy and safe to use.
本研究评估了自行使用的蓝光发光二极管疗法对面部轻至中度炎性痤疮的治疗效果,涉及以下方面:1)面部瑕疵和皮损数量改善和/或消退的时间;2)皮肤状况质量;3)新瑕疵和皮损的出现及数量;4)产品使用的便捷性;治疗期间患者的舒适度、健康状况和满意度;以及治疗的安全性。根据纳入/排除标准纳入受试者(N = 21),并在他们签署知情同意书后进行研究。蓝光治疗为期八周。使用SPSS 16.0统计软件进行研究数据的管理和分析。对于N = 20的数据,在适当情况下独立使用方差分析、学生t检验和曼-惠特尼检验进行数据管理和分析。检验在5%的显著性水平下进行。置信区间为95%。21名受试者完成了研究(21名中有18名女性,3名男性)。痤疮首次发作时,受试者的平均年龄为15岁(范围8 - 28岁),19名受试者患有轻至中度痤疮,平均病程为13.1年。在自行使用蓝光治疗的研究期间,第7天(p < 0.019)和第28天(p < 0.001)评估时,面部粉刺总数显著减少。治疗期间,第7天(p < 0.005)和第28天评估时,面部开放性粉刺(黑头)总数显著减少(p < 0.02)。治疗期间,第28天评估时,面部闭合性粉刺(白头)总数显著减少(p <